Precision Therapy in Acromegaly Caused by Pituitary Tumors: How Close Is It to Reality?
Acromegaly presents with an enigmatic range of symptoms and comorbidities caused by chronic and progressive growth hormone elevations, commonly due to endocrinologic hypersecretion from a pituitary gland tumor. Comprehensive national acromegaly databases have been appearing over the years, allowing...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Academya Publishing Co.
2020-06-01
|
Series: | Endocrinology and Metabolism |
Subjects: | |
Online Access: | http://www.e-enm.org/upload/pdf/EnM-2020-35-2-206.pdf |
id |
doaj-3cc154441a674d71bcd9b0d1f9c5a555 |
---|---|
record_format |
Article |
spelling |
doaj-3cc154441a674d71bcd9b0d1f9c5a5552020-11-25T02:49:39ZengAcademya Publishing Co.Endocrinology and Metabolism2093-596X2093-59782020-06-0135220621610.3803/EnM.2020.35.2.2062032Precision Therapy in Acromegaly Caused by Pituitary Tumors: How Close Is It to Reality?Cheol Ryong Ku0Vladimir Melnikov1Zhaoyun Zhang2Eun Jig Lee3 Division of Endocrinology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea Department of Endocrinology and Metabolism, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China Department of Endocrinology and Metabolism, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China Division of Endocrinology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, KoreaAcromegaly presents with an enigmatic range of symptoms and comorbidities caused by chronic and progressive growth hormone elevations, commonly due to endocrinologic hypersecretion from a pituitary gland tumor. Comprehensive national acromegaly databases have been appearing over the years, allowing for international comparisons of data, although still presenting varying prevalence and incidence rates. Lack of large-scale analysis in geographical and ethnic differences in clinical presentation and management requires further research. Assessment of current and novel predictors of responsiveness to distinct therapy can lead to multilevel categorization of patients, allowing integration into new clinical guidelines and reduction of increased morbidity and mortality associated with acromegaly. This review compares current data from epidemiological studies and assesses the present-day application of prognostic factors in medical practice, the reality of precision therapy, as well as its future prospects in acromegaly, with a special focus on its relevance to the South Korean population.http://www.e-enm.org/upload/pdf/EnM-2020-35-2-206.pdfacromegalyprecision medicinegrowth hormonepituitary neoplasms |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Cheol Ryong Ku Vladimir Melnikov Zhaoyun Zhang Eun Jig Lee |
spellingShingle |
Cheol Ryong Ku Vladimir Melnikov Zhaoyun Zhang Eun Jig Lee Precision Therapy in Acromegaly Caused by Pituitary Tumors: How Close Is It to Reality? Endocrinology and Metabolism acromegaly precision medicine growth hormone pituitary neoplasms |
author_facet |
Cheol Ryong Ku Vladimir Melnikov Zhaoyun Zhang Eun Jig Lee |
author_sort |
Cheol Ryong Ku |
title |
Precision Therapy in Acromegaly Caused by Pituitary Tumors: How Close Is It to Reality? |
title_short |
Precision Therapy in Acromegaly Caused by Pituitary Tumors: How Close Is It to Reality? |
title_full |
Precision Therapy in Acromegaly Caused by Pituitary Tumors: How Close Is It to Reality? |
title_fullStr |
Precision Therapy in Acromegaly Caused by Pituitary Tumors: How Close Is It to Reality? |
title_full_unstemmed |
Precision Therapy in Acromegaly Caused by Pituitary Tumors: How Close Is It to Reality? |
title_sort |
precision therapy in acromegaly caused by pituitary tumors: how close is it to reality? |
publisher |
Academya Publishing Co. |
series |
Endocrinology and Metabolism |
issn |
2093-596X 2093-5978 |
publishDate |
2020-06-01 |
description |
Acromegaly presents with an enigmatic range of symptoms and comorbidities caused by chronic and progressive growth hormone elevations, commonly due to endocrinologic hypersecretion from a pituitary gland tumor. Comprehensive national acromegaly databases have been appearing over the years, allowing for international comparisons of data, although still presenting varying prevalence and incidence rates. Lack of large-scale analysis in geographical and ethnic differences in clinical presentation and management requires further research. Assessment of current and novel predictors of responsiveness to distinct therapy can lead to multilevel categorization of patients, allowing integration into new clinical guidelines and reduction of increased morbidity and mortality associated with acromegaly. This review compares current data from epidemiological studies and assesses the present-day application of prognostic factors in medical practice, the reality of precision therapy, as well as its future prospects in acromegaly, with a special focus on its relevance to the South Korean population. |
topic |
acromegaly precision medicine growth hormone pituitary neoplasms |
url |
http://www.e-enm.org/upload/pdf/EnM-2020-35-2-206.pdf |
work_keys_str_mv |
AT cheolryongku precisiontherapyinacromegalycausedbypituitarytumorshowcloseisittoreality AT vladimirmelnikov precisiontherapyinacromegalycausedbypituitarytumorshowcloseisittoreality AT zhaoyunzhang precisiontherapyinacromegalycausedbypituitarytumorshowcloseisittoreality AT eunjiglee precisiontherapyinacromegalycausedbypituitarytumorshowcloseisittoreality |
_version_ |
1724742125201915904 |